ECD antibody |
70R-16985 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal ECD antibody |
Human IgG antibody Laboratories manufactures the spike protein ecd reagents distributed by Genprice. The Spike Protein Ecd reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike ECD. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: Ecd
ECD Recombinant Protein (Human) |
ABM |
100 ug |
Ask for price |
Human Anti-Her2 Protein (ECD domain) IgG negative control serum |
Alpha Diagnostics |
1 ml |
EUR 196.8 |
Human Anti-Her2 Protein (ECD domain) IgG positive control serum |
Alpha Diagnostics |
1 ml |
EUR 270 |
ECD Conjugated Antibody |
SAB |
100ul |
EUR 476.4 |
ECD Polyclonal Antibody |
EpiGentek |
-
EUR 684.66
-
Ask for price
-
Ask for price
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
anti- ECD antibody |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against ECD |
Ecd information
MERS-CoV Spike Protein S1 Protein, His Tag |
E40VAG204 |
EnoGene |
20ug |
EUR 495 |
SARS Spike Protein (S1 Domain) BS 6100 |
BS-6100 |
BioServUK |
1 mg |
Ask for price |
Description: SARS Spike Protein (S1 Domain) |
MERS-CoV Spike Protein S1, His Tag |
E40VAG206 |
EnoGene |
20ug |
EUR 495 |
MERS-CoV Spike Protein S2, His Tag |
E40VAG207 |
EnoGene |
20ug |
EUR 495 |
SARS-CoV-2(2019-nCoV)Spike-Protein(S2-ECD,-His-tag) |
E27D2019-P5 |
EnoGene |
2019-nCoV-Recombinant-Protein-Antigen-from-Baculovirus-Insect-Cells |
EUR 416.5 |
Description: 2019-nCoV Recombinant Protein Antigen from Baculovirus-Insect Cells |
Anti-MERSC-CoV Spike Protein antibody |
STJ140102 |
St John's Laboratory |
150 µg |
EUR 277.2 |
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases. |
COVID-19 Spike Protein a.a. 800 to 1000 |
00222-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: COVID-19 Spike Protein a.a. 800 to 1000 |
MERS Spike S1 Recombinant protein |
39-102 |
ProSci |
0.1 mg |
EUR 556.8 |
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
Recombinant SARS Spike Protein (aa 1-1190) [His] |
VAng-Lsx0063-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS Spike protein (aa 1-1190) [His], recombinant protein from HEK 293 cells. |
COVID-19 Spike S1 protein a.a. 1 to 800 |
00226-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: COVID-19 Spike S1 protein a.a. 1 to 800 |